GAPSS: the Global Anti-Phospholipid Syndrome Score

Sciascia, S., Sanna, G., Murru, V., Roccatello, D., Khamashta, M. A., Bertolaccini, M. L.·2013·Rheumatology

Cited by (318)

Items 101–200 of 318

  1. A novel aGAPSS-based nomogram for the prediction of ischemic stroke in patients with antiphospholipid syndrome
    Xiaodong Song, Yangyi Fan, Yuan Jia, Gongming Li, Meige Liu, Yicheng Xu, Jun Zhang, Chun Li · 2022 · Frontiers in Immunology
  2. Beyond the classics: The emerging value of anti-phosphatidylserine/prothrombin antibodies in antiphospholipid syndrome
    Zetao Ding, Haoyu Pan, Zhi‐Xia Yang, Chengde Yang, Hui Shi · 2023 · Clinical Immunology
  3. The Laboratory Diagnosis of the Antiphospholipid Syndrome
    Jasmina Ahluwalia, Sreejesh Sreedharanunni · 2016 · Indian Journal of Hematology and Blood Transfusion
  4. Diagnostic biologique du syndrome des antiphospholipides : des critères à la pratique
    Valentin Joste, Marie‐Agnès Dragon‐Durey, Luc Darnige · 2017 · La Revue de Médecine Interne
  5. Diagnostic performance of aPS/PT antibodies in neuropsychiatric lupus and cardiovascular complications of systemic lupus erythematosus
    Giuseppe Alvise Ramirez, Valentina Canti, Stefania Del Rosso, Roberta Erra, Lucia Moiola, Marco Magnoni, Enrica Paola Bozzolo, Angelo Andrea Manfredi, Patrizia Querini Rovere · 2019 · Autoimmunity
  6. Additional risk factors associated with thrombosis and pregnancy morbidity in a unique cohort of antiphospholipid antibody-positive patients
    Chun Li, Yu Zuo, Song Zhang, Una E. Makris, David R. Karp, Zhanguo Li · 2022 · Chinese Medical Journal
  7. Predictive value of the adjusted Global Anti-Phospholipid Syndrome Score on clinical recurrence in APS patients: a longitudinal study
    Giuseppe Barilaro, Alexandra Esteves, Carlo Della Rocca, Albert Pérez-Isidro, Olga Araújo, Gilberto Pires da Rosa, Estíbaliz Ruiz‐Ortiz, Dolors Tàssies Penella, Odette Viñas, Joan Carles Reverter et al. · 2022 · Rheumatology
  8. Antiphospholipid Syndrome: State of the Art of Clinical Management
    Luca Depietri, Maria Rosaria Veropalumbo, Maria Cristina Leone, Angelo Ghirarduzzi · 2023 · Cardiovascular Drugs and Therapy
  9. Future atherosclerotic cardiovascular disease in systemic lupus erythematosus based on CSTAR (XXVIII): the effect of different antiphospholipid antibodies isotypes
    Can Huang, Yufang Ding, Zhen Chen, Lijun Wu, Wei Wei, Cheng Zhao, Min Yang, Shudian Lin, Qian Wang, Xinping Tian et al. · 2025 · BMC Medicine
  10. Quantitative MRI adds to neuropsychiatric lupus diagnostics
    Giuseppe Alvise Ramirez, Maria Assunta Rocca, Paolo Preziosa, Enrica Paola Bozzolo, Elisabetta Pagani, Valentina Canti, Lucia Moiola, Patrizia Querini Rovere, Angelo Andrea Manfredi, Massimo Filippi · 2020 · Lara D. Veeken
  11. Development and external validation of a prediction model for venous thromboembolism in systemic lupus erythematosus
    Hanxiao You, Jiuliang Zhao, Miaojia Zhang, Ziyi Jin, Xuebing Feng, Wenfeng Tan, Lijun Wu, Xinwang Duan, Hui Luo, Cheng Zhao et al. · 2023 · RMD Open
  12. Type I interferon pathway activation across the antiphospholipid syndrome spectrum: associations with disease subsets and systemic antiphospholipid syndrome presentation
    Irene Cecchi, Massimo Radin, Alice Barinotti, Silvia Grazietta Foddai, Elisa Menegatti, Dario Roccatello, Ana Suárez, Savino Sciascia, Javier Rodríguez‐Carrio · 2024 · Frontiers in Immunology
  13. Quality of life in patients with antiphospholipid antibodies differs according to antiphospholipid syndrome damage index (DIAPS)
    Massimo Radin, Silvia Grazietta Foddai, Irene Cecchi, Dario Roccatello, Savino Sciascia · 2021 · European Journal of Internal Medicine
  14. Research trends and frontiers on antiphospholipid syndrome: A 10-year bibliometric analysis (2012–2021)
    Teng Wu, Wei Huang, Jiaping Qi, Yixuan Li, Yuan Zhang, Huan Jiang, Jing Wang, Ju Zhang, Zhao-Yu Jiang, Lin Chen et al. · 2022 · Frontiers in Pharmacology
  15. Impact of Classical Risk Factors for Arterial or Venous Thrombosis in Patients With Antiphospholipid Syndrome
    Daniel Navarro-Carpentieri, María del Carmen Castillo‐Hernández, Karim Majluf‐Cruz, Guillermo Espejo-Godinez, Paola Itzel Carmona-Olvera, Manuel Moreno‐Hernández, Yolanda Lugo, Jesús Hernández‐Juárez, Luis Loarca-Piña, Irma Isordia‐Salas et al. · 2017 · Clinical and Applied Thrombosis/Hemostasis
  16. The prevalence of antiphospholipid antibodies in women with late pregnancy complications and low‐risk for chromosomal abnormalities
    Silvia Grazietta Foddai, Massimo Radin, Irene Cecchi, Silvia Gaito, Giulia Orpheu, Elena Rubini, Alice Barinotti, Elisa Menegatti, Giulio Mengozzi, Dario Roccatello et al. · 2020 · Journal of Thrombosis and Haemostasis
  17. Novel advances on pathophysiological mechanisms, clinical manifestations, and treatment of antiphospholipid syndrome
    Qing-Nan Zhu, Xingying Qi, Shu-Wei Ren, Yuye Li, Ze-Wen Yan, Yuling Sun, Yan Shi, Qing-Si Wen, Ming‐Shiou Wu, Dapeng Wang · 2025 · Frontiers in Immunology
  18. Prevention and Treatment of Thrombotic Antiphospholipid Syndrome
    Mark Andrew Crowther, Kimberly Legault, David A. Garcia, Maria G. Tektonidou, Amaia Ugarte, Ian N Bruce, Doruk Erkan, Guillermo Ruiz‐Irastorza · 2017 · Springer eBooks
  19. Clinical profiles and risk assessment in patients with antiphospholipid antibodies
    Masaru Kato, Ryo Hisada, Tatsuya Atsumi · 2018 · Expert Review of Clinical Immunology
  20. Assessing the cardiovascular risk in patients with systemic lupus erythematosus: QRISK and GAPSS scores head-to-head
    Alice Barinotti, Massimo Radin, Irene Cecchi, Silvia Grazietta Foddai, Marta Arbrile, Elena Rubini, Elisa Menegatti, Dario Roccatello, Savino Sciascia · 2022 · International Journal of Cardiology
  21. Elevated partial antiphospholipid score is a strong risk factor for thrombosis in patients with systemic lupus erythematosus: a validation study
    Jie Chen, Shuhui Sun, Qingran Yan, Chunde Bao, Qiong Fu · 2016 · Clinical Rheumatology
  22. The impact of various entities of antiphospholipid antibodies positivity on adverse pregnancy outcome. An epidemiological perspective
    Arsenio Spinillo, Camilla Bellingeri, Irene De Maggio, Greta Riceputi, Maria Paola Pandolfi, Carolina Spada, Claudia Alpini, Carlomaurizio Montecucco, Fausta Beneventi · 2021 · Journal of Reproductive Immunology
  23. Clinical and therapeutic value of the adjusted Global Antiphospholipid Syndrome Score in primary obstetric antiphospholipid syndrome
    Sebastián Udry, Stephanie Morales-Pérez, Cristina C. Belizna, Federico Manuel Aranda, Enrique Esteve‐Valverde, Silvia D. Perés Wingeyer, Diego S Fernández-Romero, José Omar Latino, Gabriela Fernanda De Larrañaga, Jaume Alijotas‐Reig · 2022 · Lupus
  24. Improvements in diagnosis and risk assessment of primary and secondary antiphospholipid syndrome
    Petri, Michelle · 2019 · Hematology
  25. Long Term Follow up of Patients With Primary Obstetric Antiphospholipid Syndrome
    Stanley Niznik, Micha J. Rapoport, Orly Hamburger Avnery, Aharon Lubetsky, Ronen Shavit, Martin H. Ellis, Nancy Agmon‐Levin · 2022 · Frontiers in Pharmacology
  26. Diagnosis and management of obstetrical antiphospholipid syndrome: where do we stand?
    T. Marchetti, Marie Cohen, Jean‐Christophe Gris, Philippe de Moerloose · 2013 · Polskie Archiwum Medycyny Wewnętrznej
  27. Clinical-Pathological Characteristics of Renal Injuries Identify Different Clusters in Patients With Antiphospholipid Antibodies
    Savino Sciascia, Jinoos Yazdany, Gabriella Luisa Moroni, Jan Ulrich Becker, Surya V. Seshan, Danieli C. O. Andrade, Giacomo Emmi, María José Cuadrado, Massimo Radin, Irene Cecchi et al. · 2023 · Kidney International Reports
  28. The emerging role of multiple antiphospholipid antibodies positivity in patients with antiphospholipid syndrome
    Ricardo R Forastiero, Marta Elba Martinuzzo · 2015 · Expert Review of Clinical Immunology
  29. Cardiovascular disease and antiphospholipid syndrome: how to predict and how to treat?
    Ilenia Lorenza Calcaterra, Antonella Tufano, Roberta Lupoli, Gabriella Iannuzzo, Giacomo Emmi, Matteo Nicola Dario Di Minno · 2020 · Polskie Archiwum Medycyny Wewnętrznej
  30. Antiphospholipid syndrome: the need for new international classification criteria
    Georges El Hasbani, Ali T. Taher, Savino Sciascia, Imad W. Uthman · 2021 · Expert Review of Clinical Immunology
  31. Biological markers of high risk of thrombotic recurrence in patients with antiphospholipid syndrome: A literature review
    Mathilde Lambert, Alexandre Brodovitch, Jean‐Louis Mège, Daniel Bertin, Nathalie Bardin · 2024 · Autoimmunity Reviews
  32. Utilizing type I interferon expression in the identification of antiphospholipid syndrome subsets
    Irene Cecchi, Massimo Radin, Javier Rodríguez‐Carrio, Ajay Tambralli, Jason S. Knight, Savino Sciascia · 2021 · Expert Review of Clinical Immunology
  33. Associations with thrombosis are stronger for antiphosphatidylserine/prothrombin antibodies than for the Sydney criteria antiphospholipid antibody tests in SLE
    Sahwa Elbagir, Giorgia Grosso, NasrEldeen A Mohammed, Amir Elshafie, Elnour Mohammed Elagib, Agneta Zickert, Vivek Anand Manivel, Eleftheria Pertsinidou, Musa AM Nur, Iva Gunnarsson et al. · 2021 · Lupus
  34. Differential diagnostic performance of PET/CT in adult-onset still’s disease and lymphoma: a retrospective pilot study
    Liyan Wan, Yuting Gao, Chendie Yang, Jieyu Gu, Tingting Liu, Qiongyi Hu, Zihan Tang, Jialin Teng, Honglei Liu, Xiaobing Cheng et al. · 2022 · Quantitative Imaging in Medicine and Surgery
  35. Duration of Anticoagulation Treatment for Thrombosis in APS: Is It Ever Safe to Stop?
    Sinthiya Punnialingam, Munther A. Khamashta · 2013 · Current Rheumatology Reports
  36. Current status and future prospects for the treatment of antiphospholipid syndrome
    Ahlam Al Marzooqi, Alessia Leone, Jamal Al Saleh, Munther A. Khamashta · 2016 · Expert Review of Clinical Immunology
  37. Antiphospholipid syndrome and the relevance of antibodies to negatively charged phospholipids in diagnostic evaluation
    AE Tebo · 2014 · Lupus
  38. Modulation of trophoblast function by concurrent hyperglycemia and antiphospholipid antibodies is in part TLR 4‐dependent
    Daisy León-Martínez, Melissa J. Mulla, Christina S. Han, Larry Chamley, Vikki M. Abrahams · 2018 · American Journal of Reproductive Immunology
  39. Anti-phosphatidylserine/prothrombin antibodies and thrombosis associate positively with HLA-DRB1*13 and negatively with HLA-DRB1*03 in SLE
    Sahwa Elbagir, Lina-Marcela Díaz-Gallo, Giorgia Grosso, Agneta Zickert, Iva Gunnarsson, Michael Mähler, Elisabet Svenungsson, Johan Rönnelid · 2022 · Lara D. Veeken
  40. Risk factors and recurrent thrombosis in primary antiphospholipid syndrome
    Fariza A. Cheldieva, Anastasiia A. Shumilova, Mariya V. Cherkasova, Svetlana I. Glukhova, Aleksander M. Lila, Evgeny Lvovich Nasonov, Tatiana Magomedalievna Reshetnyak · 2023 · Exploration of Immunology
  41. Avascular Necrosis of the Femoral Head in Patients with Antiphospholipid Syndrome: A Case Series
    Paschalis Evangelidis, Eleni Gavriilaki, Nikolaos Kotsiou, Zacharo Ntova, Panagiotis Kalmoukos, Theodosia Papadopoulou, Sofia Chissan, Sofia Vakalopoulou · 2025 · Hematology Reports
  42. Management of patients with antiphospholipid antibodies: what to do in laboratory scenarios that do not fit the guidelines
    Gilberto Pires da Rosa, Ignasi Rodríguez‐Pintó, Ricard Cervera, Gerard Espinosa · 2021 · Expert Review of Hematology
  43. Ethnicity and Antiphospholipid Syndrome in Israel
    Stanley Niznik, Micha J. Rapoport, Orly Hamburger Avnery, Martin H. Ellis, Soad Haj Yahia, Nancy Agmon‐Levin · 2021 · Arthritis Care & Research
  44. Validation of three prediction models for thrombosis recurrence in antiphospholipid syndrome patients based on a prospective cohort
    Yuan Zhao, Can Liang Huang, Wanting Qi, Yangzhong Zhou, Jiuliang Zhao, Qian Wang, Xinping Tian, Mengtao Li, Yan Zhao, Xiaofeng Zeng · 2023 · RMD Open
  45. Validation of the adjusted global antiphospholipid syndrome score in a single centre cohort of APS patients from Turkey
    Ömer Uludağ, Murat Bektaş, Erhan Çene, Murat Sezer, Yasemin Şahinkaya, Ahmet Gül, Murat İnanç, Lale Öçal, Bahar Artım-Esen · 2020 · Journal of Thrombosis and Thrombolysis
  46. Validation of the Particle-Based Multi-Analyte Technology for Detection of Anti-PhosphatidylSerine/Prothrombin Antibodies
    Massimo Radin, Irene Cecchi, Silvia Grazietta Foddai, Elena Rubini, Alice Barinotti, Carlos Ramirez, Andrea Seaman, Dario Roccatello, Michael Mähler, Savino Sciascia · 2020 · Biomedicines
  47. Comparative analysis of different enzyme immunoassays for assessment of phosphatidylserine-dependent antiprothrombin antibodies
    Olga Amengual, Tetsuya Horita, Walter L. Binder, Gary L. Norman, Zakera Shums, Masaru Kato, Kotaro Otomo, Yuichiro Fujieda, Kenji Oku, Toshiyuki Bohgaki et al. · 2014 · Rheumatology International
  48. Acute Coronary Syndromes in Antiphospholipid Syndrome-above Suspicion: A Systematic Review
    Vasileios Nevras, Nikias Milaras, Christos Katsioulis, Zoi Sotiriou, Sotirios Tsalamandris, Georgia Gkounti, Skevos K. Sideris · 2022 · Current Problems in Cardiology
  49. Early Prediction of Adverse Pregnancy Outcome in Women with Systemic Lupus Erythematosus, Antiphospholipid Syndrome, or Non-Criteria Obstetric Antiphospholipid Syndrome
    Núria Baños, Aleida Susana Castellanos Gutierrez, Giuseppe Barilaro, F. Figueras, Gema Maria Lledó, Marta Santana, Gerard Espinosa · 2022 · Journal of Clinical Medicine
  50. Anti-beta-2-glycoprotein I domain 1 identifies antiphospholipid antibodies-related injuries in patients with concomitant lupus nephritis
    Savino Sciascia, Massimo Radin, Irene Cecchi, Roberta Fenoglio, Andrea De Marchi, Luca Besso, Simone Baldovino, Daniela Rossi, Paolo Miraglia, Elena Rubini et al. · 2020 · Journal of Nephrology
  51. Acute Myocardial Infarction Due to Antiphospholipid Syndrome – Case Report and Review of the Literature
    Karolina Semczuk-Kaczmarek, Anna Edyta Platek, Anna Ryś-Czaporowska, Filip M. Szymański, Krzysztof Jerzy Filipiak · 2020 · Current Problems in Cardiology
  52. Risk Assessment and Antithrombotic Strategies in Antiphospholipid Antibody Carriers
    Ilenia Lorenza Calcaterra, Pasquale Ambrosino, Nicoletta Vitelli, Roberta Lupoli, Roberta Clara Orsini, Martina Chiurazzi, Mauro Maniscalco, Matteo Nicola Dario Di Minno · 2021 · Biomedicines
  53. Identifying Additional Risk Factors for Thrombosis and Pregnancy Morbidities Among Antiphospholipid Antibodies Carriers
    Zuo, Yu, Fan, Jennifer, Sarode, Ravi, Zhang, Song, Makris, Una E., Karp, David R., Shen, Yu-Min · 2018 · Clinical and Applied Thrombosis/Hemostasis
  54. Antiphospholipid antibodies and atherosclerotic vascular disease: recent advances
    Anetta Undas, Jacek Musiał, Michał Ząbczyk · 2025 · Rheumatology International
  55. Heart valve disease in primary antiphospholipid syndrome
    Stanley Niznik, Micha J. Rapoport, Orly Hamburger Avnery, Mona Iancovici Kidon, Ronen Shavit, Martin H. Ellis, Nancy Agmon‐Levin · 2023 · Lara D. Veeken
  56. Anti-β2GPI-domain I antibody is associated with extra-criteria manifestations in a large prospective antiphospholipid syndrome cohort in China
    Yangzhong Zhou, Chaojun Hu, Wanting Qi, Yin Long, Can Liang Huang, Qian Wang, Xinping Tian, Jiuliang Zhao, Mengtao Li, Xiaofeng Zeng · 2023 · Lupus Science & Medicine
  57. Non-criteria antiphospholipid antibodies and calprotectin as potential biomarkers in pediatric antiphospholipid syndrome
    Elizabeth E. Sloan, Katarína Kmeťová, Somanathapura K. NaveenKumar, Lyndsay Kluge, Emily Chong, Claire K. Hoy, Srilakshmi Yalavarthi, Cyrus Sarosh, Jeanine M. Baisch, Lynnette Walters et al. · 2024 · Clinical Immunology
  58. Increased heterogeneity of brain perfusion is an early marker of central nervous system involvement in antiphospholipid antibody carriers
    Ting‐Syuan Lin, Pei-Ying Hsu, Chin‐Hao Chang, Chi‐Lun Ko, Yu‐Min Kuo, Yen‐Wen Wu, Ruoh‐Fang Yen, Cheng-Han Wu, Ko‐Jen Li, Yenh-Chen Hsein et al. · 2017 · PLoS ONE
  59. Elevated IgA antiphospholipid antibodies in healthy pregnant women in Sudan but not Sweden, without corresponding increase in IgA anti-β 2 glycoprotein I domain 1 antibodies
    Sahwa Elbagir, NasrEldeen A Mohammed, Helena Kaihola, Elisabet Svenungsson, Iva Gunnarsson, Vivek Anand Manivel, Eleftheria Pertsinidou, Elnour Mohammed Elagib, Musa AM Nur, Elsir A. Elussein et al. · 2020 · Lupus
  60. Validation of the adjusted global antiphospholipid syndrome score in systemic lupus erythematosus patients in Argentina
    Lucila García, María Sofía Velloso, María Victoria Martiré, Florencia Savy, Fernando Arizpe, Nadia Garcia, Adriana Carina Testi, Claudia Peña, Ana Carolina Costi, C. A. Isnardi et al. · 2020 · Lupus
  61. Cerebrovascular events in patients with isolated anti-phosphatidyl-serine/prothrombin antibodies
    Massimo Radin, Alice Barinotti, Silvia Grazietta Foddai, Irene Cecchi, Elena Rubini, Dario Roccatello, Elisa Menegatti, Savino Sciascia · 2021 · Immunologic Research
  62. Update on the Diagnosis and Anticoagulant Treatment of the Antiphospholipid Syndrome
    Nicoletta Riva, Alex Gatt · 2019 · EMJ Rheumatology
  63. High-throughput sequencing technology facilitates the discovery of novel biomarkers for antiphospholipid syndrome
    Qi Liu, Shuo Yang, Yuan Tan, Liyan Cui · 2023 · Frontiers in Immunology
  64. Small-Extracellular-Vesicle-Derived miRNA Profile Identifies miR-483-3p and miR-326 as Regulators in the Pathogenesis of Antiphospholipid Syndrome (APS)
    Cristina Solé, Maria Royo, Sebastian Sandoval, Teresa Moliné, Josefina Cortés-Hernández · 2023 · International Journal of Molecular Sciences
  65. Risk factors for ischemic antiphospholipid syndrome: A case-control study
    Roxana Matus Mayorga, Ana Barrera‐Vargas, Marina Rull‐Gabayet, Eduardo Aguirre-Aguilar, Martín Valdez-López, Fernando Espinosa-Lira, Cristina Ramos-Ventura, Vanessa Cano-Nigenda, Miguel Angel Barboza, Javier Merayo‐Chalico et al. · 2021 · Clinical Neurology and Neurosurgery
  66. Efficacy of a hypolipid diet in patients with primary antiphospholipid syndrome with dyslipidemia: a prospective study
    Thays de Cássia Ruiz Rodrigues, Camila de Oliveira Vaz, ELIANA CRISTINA MARTINS MIRANDA, Marcos Emanoel Pereira, Sabrina da Silva Saraiva, Joyce Maria Annichino‐Bizzacchi, Bruna de Moraes Mazetto, Fernanda Andrade Orsi · 2021 · Journal of Thrombosis and Thrombolysis
  67. Identification of common MicroRNAs expression signatures in antiphospholipid syndrome and thromboembolic disease: A scoping review
    Camila de Oliveira Vaz, Bruna Cardoso Jacintho, Gabrielle de Mello Santos, José Diogo Oliveira, Bruna de Moraes Mazetto, Murilo Vieira Geraldo, Fernanda Andrade Orsi · 2024 · Lupus
  68. Criteria and non-criteria anti-phospholipid antibodies in the different clinical forms of antiphospholipid syndrome
    Óscar Cabrera-Marante, Daniel Enrique Pleguezuelo, Sara Garcinuño, Laura Naranjo, Raquel Díaz‐Simón, Francisco Javier Gil‐Etayo, Denis Zafra, Fernando Lozano-Morillo, Luis Morillas, Magdalena Abad et al. · 2025 · Frontiers in Immunology
  69. Antiphospholipid Syndrome and Kidney Involvement
    Emanuele De Simone, Savino Sciascia, Roberta Fenoglio, Valentina Oddone, Antonella Barreca, Dario Roccatello · 2023 · Kidney & Blood Pressure Research
  70. Performance of the 2023 American College of Rheumatology/ EULAR Classification Criteria for Antiphospholipid Syndrome in a Mexican Cohort
    Erik Cimé‐Aké, Gabriela Hernández‐Molina, Amaya Llorente‐Chávez, Eduardo Martín‐Nares · 2024 · Arthritis & Rheumatology
  71. The adjusted Global Anti-Phospholipid Syndrome Score as predictor of damage accrual measured by Damage Index for APS: a longitudinal study
    Giuseppe Barilaro, Carlo Della Rocca, Alexandra Esteves, Ricard Cervera, Gerard Espinosa · 2022 · Rheumatology
  72. Top 10 Clinical Research Developments in Antiphospholipid Syndrome
    Medha Barbhaiya, Doruk Erkan · 2013 · Current Rheumatology Reports
  73. Multifocal avascular osteonecrosis despite appropriate anticoagulation therapy in a patient with systemic lupus erythematosus and antiphospholipid syndrome
    Irene Cecchi, Laura Pérez Sánchez, Savino Sciascia, Dario Roccatello · 2018 · BMJ Case Reports
  74. Syndrome des antiphospholipides « séronégatif » : mythe ou réalité ?
    Valéry Salle · 2020 · La Revue de Médecine Interne
  75. Risk Factors and Outcomes of Acute Myocardial Infarction in a Cohort of Antiphospholipid Syndrome
    Yuzhou Gan, Yawei Zhao, Gongming Li, Hua Ye, Yunshan Zhou, Chang Jun Hou, Lan Wang, Jianping Guo, Chun Li · 2022 · Frontiers in Cardiovascular Medicine
  76. Thrombotic risk in antiphospholipidic syndrome: From hypothesis to current evidence (Review)
    Claudia Mihaela Gavris, Laurențiu Dănuț Nedelcu, Alina Mihaela Pascu · 2021 · Experimental and Therapeutic Medicine
  77. The Validation of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria in a Cohort from Turkey
    Salim Mısırcı, Ali Ekin, Burcu Yağız, Belkıs Nihan Coşkun, Ediz Dalkılıç, Yavuz Pehlivan · 2024 · Diagnostics
  78. Development of a risk prediction model for the first occurrence of thrombosis in patients with OAPS
    Jie Gao, Yan Zheng, Zhuo Wang, Junfeng Jia, Jian Wan, Qing Han, Xi Zheng, Renli Liu, Zhaohui Zheng, Kaichun Wu et al. · 2024 · Frontiers in Immunology
  79. Summary of the 9th meeting of the European Forum on Antiphospholipid Antibodies
    Jakub Swadźba, Wojciech Sydor, J Kołodziejczyk, Jacek Musiał · 2014 · Lupus
  80. Incidence of a First Thrombo-Embolic Event in Patients With Systemic Lupus Erythematosus and Anti-phosphatidylserine/prothrombin Antibodies: A Prospective Study
    Savino Sciascia, Massimo Radin, Irene Cecchi, Elena Rubini, Silvia Grazietta Foddai, Alice Barinotti, Antonella Vaccarino, Daniela Rossi, Dario Roccatello · 2021 · Frontiers in Medicine
  81. Distinct features of youth-onset primary antiphospholipid syndrome
    Carla Baleeiro, Camila SC Duran, Flávio Signorelli, Gustavo Guimarães Moreira Balbi, Eloísa Bonfá, Danieli C. O. Andrade · 2021 · Lupus
  82. Apport de la détection des anticorps antiphosphatidylsérine/prothrombine (aPS/PT) dans le diagnostic et la prise en charge du syndrome des antiphospholipides (SAPL)
    A Delarue, Marie‐Agnès Dragon‐Durey, Luc Darnige · 2022 · La Revue de Médecine Interne
  83. Diagnóstico en el síndrome antifosfolipídico: desde una perspectiva histórica a la aparición de nuevos autoanticuerpos
    Oscar Ardila-Suarez, José Alfredo Gómez-Puerta, Munther A. Khamashta · 2016 · Medicina Clínica
  84. Antiphospholipid Syndrome
    Tadej Avčin, Kathleen M. O’Neil · 2015 · Elsevier eBooks
  85. Lupus und Thrombophilie
    Marie Lettau, Eva Vanessa Schrezenmeier, Christof Specker, Thomas Dörner · 2020 · Zeitschrift für Rheumatologie
  86. The antiphospholipid syndrome
    Giuseppe Barilaro, Gerard Espinosa, Ricard Cervera · 2021 · Revista Colombiana de Reumatología
  87. Clinical implications of the detection of antibodies directed against domain 1 of β2-glycoprotein 1 in thrombotic antiphospholipid syndrome
    Silmara Aparecida de Lima Montalvão, Priscila Soares Elídio, Sabrina da Silva Saraiva, Bruna de Moraes Mazetto, Marina Pereira Colella, Erich Vinícius De Paula, Simone Appenzeller, Joyce Maria Annichino‐Bizzacchi, Fernanda Andrade Orsi · 2016 · Thrombosis Research
  88. Antiphospholipid syndrome
    Nobuya Abe, Tatsuya ATSUMI · 2018 · Japanese Journal of Thrombosis and Hemostasis
  89. Precision medicine and the antiphospholipid syndrome: what is the future?
    Ignasi Rodríguez‐Pintó, Gerard Espinosa, Ricard Cervera · 2020 · Clinical Rheumatology
  90. Adjusted global antiphospholipid syndrome score (aGAPSS) is useful to predict relapses in patients with retinal vein occlusion
    José L. Hernández, José Javier Napal, Miguel Icardo, Paula González Bores, Rocío Pérez‐Montes, Andrea Cerveró, Zaida Salmón, José Manuel Olmos, Víctor Manuel Martínez-Taboada · 2022 · Thrombosis Research
  91. Ocular involvement in primary antiphospholipid syndrome: results of an extensive ophthalmological evaluation performed in the APS-Rio cohort
    Adriana Miranda de Magalhães Franco, Lana Sayuri Makita, Virginia C Perrut, Gustavo Guimarães Moreira Balbi, Alexandre Mendonça de Barros, Flávio Mac Cord Medina, Flávio Signorelli · 2022 · Lupus
  92. Length of exposure to antiphospholipid antibodies, rather than age, is a risk factor for thrombosis: a retrospective single-centre observational study
    Íñigo Les, Naiara Parraza, Pilar Anaut, Saioa Eguiluz, Cristina Sánchez, María Enriqueta Preciado, Jesús Ángel Loza, Ander Andía · 2017 · Rheumatology International
  93. Global Antiphospholipid Syndrome Score (GAPSS) in patients with primary antiphospholipid syndrome
    Fariza A. Cheldieva, Tatiana Magomedalievna Reshetnyak, Anastasiia A. Shumilova, Kamila S. Nurbaeva, Mariya V. Cherkasova, Elena Yu. Samarkina, Aleksander M. Lila · 2023 · Modern Rheumatology Journal
  94. Risk Factors for Recurrent Thrombosis in Patients with Antiphospholipid Syndrome—A Single-Centre Cohort Study
    Natali Karandyszowska, Francesca Faustini, Hevgin Alagündüz, Jacob Widaeus, Felicia Carlens, Ann-Louise Jensen, Anna Oksanen, Maria Magnusson, Iva Gunnarsson, Elisabet Svenungsson et al. · 2025 · TH Open
  95. 2023 ACR/EULAR classification criteria for antiphospholipid syndrome: more lights rise but shade remains
    Jaume Alijotas‐Reig, Francesc Miró‐Mur, Ariela Hoxha, Munther A. Khamashta, Yehuda Shoenfeld · 2025 · RMD Open
  96. Development of a new scoring system for predicting recurrent thrombosis in patients with antiphospholipid syndrome
    Oh Chan Kwon, Jang Woo Ha, Min‐Chan Park, Yong‐Beom Park, Sang‐Won Lee · 2025 · Revista Brasileira de Reumatologia
  97. Are the 2023 ACR/EULAR classification criteria a step forward in the management of antiphospholipid syndrome? A literature-based and clinical practice appraisal
    Jaume Alijotas‐Reig, Joana Rita Marques-Soares, Enrique Esteve‐Valverde, Ariadna Anunciación-Llunell, Catalina Andrada, Monika Očková, Ariela Hoxha, Munther A. Khamashta, Yehuda Shoenfeld, Francesc Miró‐Mur · 2025 · Autoimmunity Reviews
  98. Severe thrombocytopenia in antiphospholipid syndrome: a retrospective study of 432 patients
    Carine Schmidt, Matthias Papo, Dov Taieb, Raphaël Lhote, Miguel Hie, Micheline Pha, Julien Haroche, Fleur Cohen Aubart, P.L. Cariou, Nassim Ait Abdallah et al. · 2026 · RMD Open
  99. Assessment of the activity and organ damage in antiphospholipid syndrome
    Fariza A. Cheldieva, Tatiana Magomedalievna Reshetnyak, Aleksander M. Lila · 2021 · Modern Rheumatology Journal
  100. Global antiphospholipid syndrome score (GAPSS) in patients with systemic lupus erythematosus
    Fariza A. Cheldieva, Tatiana Magomedalievna Reshetnyak, Anastasiia A. Shumilova, Kamila S. Nurbaeva, Mariya V. Cherkasova, Aleksander M. Lila, Evgeny Lvovich Nasonov · 2022 · Rheumatology Science and Practice